Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGY) was the target of a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 1,600 shares, a drop of 97.2% from the November 15th total of 56,900 shares. Based on an average trading volume of 245,500 shares, the short-interest ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group started coverage on Merck KGaA in a research report on Thursday, September 19th. They set a “buy” rating for the company.

Merck KGaA Stock Performance

Shares of MKKGY traded down $0.24 during trading hours on Friday, reaching $29.51. 159,143 shares of the company’s stock traded hands, compared to its average volume of 72,295. The firm has a market capitalization of $19.07 billion, a price-to-earnings ratio of 18.36, a P/E/G ratio of 2.37 and a beta of 0.93. The business’s fifty day simple moving average is $32.01 and its two-hundred day simple moving average is $34.48. Merck KGaA has a twelve month low of $28.96 and a twelve month high of $39.17. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.33 and a quick ratio of 0.91.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.